Skip to main content

Table 3 Absolute and relative educational inequalities in site-specific cancer mortality among Belgian men aged 50–79 years for the period 2001–2008

From: Evolution of educational inequalities in site-specific cancer mortality among Belgian men between the 1990s and 2000s using a “fundamental cause” perspective

Cancer site

 

Total population

Low educated c

Mid educated d

High educated e

MRD f,g (95% CI h)

Total cancer mortality

ASMR a

687.0 (682.0–692.1)

729.8 (722.8–736.8)

612.6 (600.5–624.6)

491.4 (480.1–502.7)

238.4 (234.1–242.7)

MRR b

 

1.55 (1.52–1.59)

1.29 (1.25–1.33)

1.00

 

Head and neck

ASMR

30.7 (29.6–31.7)

33.4 (31.8–34.9)

26.4 (24.0–28.8)

18.7 (16.6–20.7)

14.7 (14.2–15.2)

MRR

 

1.95 (1.74–2.19)

1.50 (1.31–1.72)

1.00

 

Oesophagus

ASMR

24.6 (23.6–25.5)

24.9 (23.6–26.2)

25.1 (22.7–27.5)

21.4 (19.1–23.7)

3.5 (2.5–4.5)

MRR

 

1.26 (1.12–1.42)

1.24 (1.08–1.43)

1.00

 

Stomach

ASMR

22.0 (21.1–22.9)

23.8 (22.5–25.0)

17.2 (15.1–19.2)

16.1 (14.0–18.1)

7.7 (6.9–8.5)

MRR

 

1.50 (1.31–1.72)

1.09 (0.92–1.29)

1.00

 

Colorectal

ASMR

65.9 (64.3–67.4)

66.2 (64.1–68.3)

63.2 (59.3–67.1)

52.4 (50.4–58.0)

13.8 (10.3–13.7)

MRR

 

1.25 (1.16–1.34)

1.19 (1.09–1.30)

1.00

 

Liver

ASMR

19.5 (18.6–20.3)

18.8 (17.7–20.0)

20.7 (18.5–22.9)

18.9 (16.7–21.2)

−0.1 (−1.2–1.0)

MRR

 

1.10 (0.96–1.25)

1.20 (1.03–1.41)

1.00

 

Pancreas

ASMR

33.2 (32.0–34.3)

33.8 (32.3–35.3)

31.3 (28.5–34.0)

33.5 (30.5–36.5)

0.3 (−1.2–1.8)

MRR

 

1.07 (0.97–1.18)

0.98 (0.87–1.11)

1.00

 

Lung and trachea

ASMR

252.9 (249.9–256.0)

286.1 (281.7–290.5)

196.7 (189.9–203.6)

134.4 (128.5–140.3)

151.7 (150.2–153.2)

MRR

 

2.23 (2.13–2.33)

1.52 (1.44–1.60)

1.00

 

Melanoma

ASMR

6.0 (5.5–6.5)

5.8 (5.2–6.4)

7.0 (5.8–8.3)

6.4 (5.2–7.7)

−0.6 (−1.3–0.0)

MRR

 

0.89 (0.72–1.11)

1.05 (0.81–1.35)

1.00

 

Prostate

ASMR

48.4 (47.0–49.7)

47.7 (45.9–49.4)

46.7 (43.2–50.2)

43.7 (40.2–47.3)

4.0 (2.1–5.7)

MRR

 

1.11 (1.02–1.21)

1.06 (0.95–1.18)

1.00

 

Kidney

ASMR

18.9 (18.0–19.7)

19.1 (18.0–20.2)

20.1 (17.8–22.3)

16.8 (14.7–18.9)

2.3 (1.3–3.3)

MRR

 

1.15 (1.00–1.31)

1.17 (0.99–1.37)

1.00

 

Bladder

ASMR

24.8 (23.8–25.8)

25.3 (24.0–26.6)

23.3 (20.8–25.7)

17.8 (15.6–20.0)

7.5 (6.6–8.4)

MRR

 

1.49 (1.30–1.70)

1.34 (1.14–1.57)

1.00

 

Eye, brain, central nervous system

ASMR

14.9 (14.2–15.7)

14.9 (13.9–15.9)

14.8 (13.0–16.7)

14.1 (12.3–15.9)

0.8 (0.0–1.6)

MRR

 

1.06 (0.92–1.22)

1.04 (0.88–1.24)

1.00

 

Non-Hodgkin Lymphoma

ASMR

14.4 (13.7–15.1)

13.9 (13.0–14.9)

15.9 (13.9–17.9)

13.2 (11.3–15.1)

0.7 (−0.2–1.7)

MRR

 

1.09 (0.93–1.27)

1.23 (1.02–1.47)

1.00

 

Multiple myeloma

ASMR

9.8 (9.2–10.4)

9.9 (9.1–10.7)

10.8 (9.2–12.5)

8.6 (7.1–10.1)

1.3 (0.6–2.0)

MRR

 

1.12 (0.93–1.35)

1.20 (0.96–1.51)

1.00

 

Leukaemia

ASMR

18.9 (18.1–19.8)

18.8 (17.7–19.9)

19.1 (16.9–21.3)

17.2 (15.0–19.4)

1.6 (0.5–2.7)

MRR

 

1.14 (0.99–1.31)

1.12 (0.95–1.33)

1.00

 
  1. aAge-standardized mortality rate using the Belgian population at the moment of the 2001 census as reference; expressed per 100,000 men
  2. bMortality Rate Ratio
  3. cLow-educated persons have completed lower secondary education or less
  4. dMid-educated persons have completed upper secondary education
  5. eHigh-education persons have completed tertiary education
  6. fMortality rate difference
  7. gThe difference between the ASMR of the lowest educated and the ASMR of the highest educated
  8. h95% Confidence Intervals
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us